Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology
Top Cited Papers
- 9 July 2019
- journal article
- review article
- Published by Elsevier BV in Neuropharmacology
- Vol. 172, 107704
- https://doi.org/10.1016/j.neuropharm.2019.107704
Abstract
No abstract availableKeywords
Funding Information
- LSD
- National Institute of Mental Health
- NIMH
This publication has 245 references indexed in Scilit:
- Extrasynaptic GABAA Receptors: Their Function in the CNS and Implications for DiseaseNeuron, 2012
- Hippocampal interneurons are abnormal in schizophreniaSchizophrenia Research, 2011
- Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET studyMolecular Psychiatry, 2011
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysisSchizophrenia Research, 2010
- Striatal and extrastriatal dopamine release measured with PET and [18F] fallyprideSynapse, 2009
- Meta-analysis of 41 Functional Neuroimaging Studies of Executive Function in SchizophreniaArchives of General Psychiatry, 2009
- Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoPsychopharmacology, 2009
- Results of phase 3 of the CATIE schizophrenia trialSchizophrenia Research, 2009
- Rolipram: A specific phosphodiesterase 4 inhibitor with potential antipsychotic activityNeuroscience, 2007
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973